{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T21:16:01Z","timestamp":1774127761246,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24514-6","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:20:20Z","timestamp":1763554820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Site-directed tyrosinase conjugation on engineered ferritin retains immune recognition"],"prefix":"10.1038","volume":"15","author":[{"given":"Margarida Q.","family":"Rodrigues","sequence":"first","affiliation":[]},{"given":"M\u00f3nica","family":"Thomaz","sequence":"additional","affiliation":[]},{"given":"Ricardo A.","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Paula M.","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Rold\u00e3o","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"24514_CR1","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nri2868","volume":"10","author":"MF Bachmann","year":"2010","unstructured":"Bachmann, M. F. & Jennings, G. T. Vaccine delivery: A matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol. 10, 787\u2013796 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"24514_CR2","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3390\/pharmaceutics13101621","volume":"13","author":"MQ Rodrigues","year":"2021","unstructured":"Rodrigues, M. Q., Alves, P. M. & Rold\u00e3o, A. Functionalizing ferritin nanoparticles for vaccine development. Pharmaceutics. 13, 1621 (2021).","journal-title":"Pharmaceutics."},{"key":"24514_CR3","doi-asserted-by":"publisher","first-page":"e581","DOI":"10.1016\/S2666-5247(23)00410-X","volume":"5","author":"BLO Shepherd","year":"2024","unstructured":"Shepherd, B. L. O. et al. SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: A phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial. Lancet Microbe. 5, e581\u2013e593 (2024).","journal-title":"Lancet Microbe."},{"key":"24514_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41591-021-01660-8","volume":"28","author":"KV Houser","year":"2022","unstructured":"Houser, K. V. et al. Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: A phase 1 trial. Nat. Med. 28, 383\u2013391 (2022).","journal-title":"Nat. Med."},{"key":"24514_CR5","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1126\/scitranslmed.ade4790","volume":"15","author":"AT Widge","year":"2023","unstructured":"Widge, A. T. et al. An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults. Sci. Transl. Med. 15, 4790 (2023).","journal-title":"Sci. Transl. Med."},{"key":"24514_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-024-00959-0","volume":"9","author":"JP Casazza","year":"2024","unstructured":"Casazza, J. P. et al. Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine. npj Vaccines. 9, 1\u201310 (2024).","journal-title":"npj Vaccines."},{"key":"24514_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.partic.2021.04.001","volume":"64","author":"Y Sheng","year":"2022","unstructured":"Sheng, Y. et al. Apoferritin nanoparticle based dual-antigen influenza conjugate vaccine with potential cross-protective efficacy against heterosubtypic influenza virus. Particuology. 64, 56\u201364 (2022).","journal-title":"Particuology."},{"key":"24514_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.biomaterials.2016.05.006","volume":"98","author":"L Li","year":"2016","unstructured":"Li, L. et al. Ferritin-mediated siRNA delivery and gene silencing in human tumor and primary cells. Biomaterials 98, 143\u2013151 (2016).","journal-title":"Biomaterials"},{"key":"24514_CR9","doi-asserted-by":"publisher","first-page":"22487","DOI":"10.1021\/acsanm.4c02093","volume":"7","author":"L-M Qin","year":"2024","unstructured":"Qin, L.-M., Feng, M.-F., Sun, B., Yu, X. & Wu, Y. Targeted delivery of BCL-2 siRNA using modified ferritin nanocarriers for antitumor therapy. ACS Appl. Nano. Mater. 7, 22487\u201322496 (2024).","journal-title":"ACS Appl. Nano. Mater."},{"key":"24514_CR10","doi-asserted-by":"publisher","first-page":"779976","DOI":"10.3389\/fchem.2021.779976","volume":"9","author":"Y-H Wang","year":"2021","unstructured":"Wang, Y.-H. et al. Ferritin conjugates with multiple clickable amino acids encoded by c-terminal engineered Pyrrolysyl-tRNA Synthetase. Front. Chem. 9, 779976 (2021).","journal-title":"Front. Chem."},{"key":"24514_CR11","doi-asserted-by":"publisher","first-page":"8601","DOI":"10.1038\/s41467-024-52908-z","volume":"15","author":"D Fu","year":"2024","unstructured":"Fu, D. et al. Self-assembling nanoparticle engineered from the ferritinophagy complex as a rabies virus vaccine candidate. Nat. Commun. 15, 8601 (2024).","journal-title":"Nat. Commun."},{"key":"24514_CR12","first-page":"1608","volume":"35","author":"MQ Rodrigues","year":"2024","unstructured":"Rodrigues, M. Q. et al. Tyrosinase-mediated conjugation for antigen display on ferritin nanoparticles. Bioconjugate Chem. 35, 1608\u20131617 (2024).","journal-title":"Bioconjugate Chem."},{"key":"24514_CR13","doi-asserted-by":"publisher","first-page":"101614","DOI":"10.1016\/j.xcrm.2024.101614","volume":"5","author":"Q Fang","year":"2024","unstructured":"Fang, Q. et al. Development of a PCSK9-targeted nanoparticle vaccine to effectively decrease the hypercholesterolemia. Cell. Rep. Med. 5, 101614 (2024).","journal-title":"Cell. Rep. Med."},{"key":"24514_CR14","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.immuni.2020.11.015","volume":"53","author":"X Ma","year":"2020","unstructured":"Ma, X. et al. Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses. Immunity 53, 1315-1330.e9 (2020).","journal-title":"Immunity"},{"key":"24514_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s12951-023-02210-9","volume":"21","author":"J Song","year":"2023","unstructured":"Song, J. et al. A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response. J. Nanobiotechnol. 21, 424 (2023).","journal-title":"J. Nanobiotechnol."},{"key":"24514_CR16","doi-asserted-by":"publisher","first-page":"9872","DOI":"10.3390\/ijms25189872","volume":"25","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Glycoprotein E-displaying nanoparticles induce robust neutralizing antibodies and T-Cell response against varicella zoster virus. Int. J. Mol. Sci. 25, 9872 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"24514_CR17","doi-asserted-by":"publisher","first-page":"1328266","DOI":"10.3389\/fimmu.2024.1328266","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Nanoparticle vaccines based on the receptor binding domain of porcine deltacoronavirus elicit robust protective immune responses in mice. Front. Immunol. 15, 1328266 (2024).","journal-title":"Front. Immunol."},{"key":"24514_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3390\/vaccines12060629","volume":"12","author":"D Zhong","year":"2024","unstructured":"Zhong, D. et al. Ferritin nanoparticle delivery of the E2 protein of classical swine fever virus completely protects pigs from lethal challenge. Vaccines 12, 629 (2024).","journal-title":"Vaccines"},{"key":"24514_CR19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41423-021-00643-6","volume":"18","author":"W Wang","year":"2021","unstructured":"Wang, W., Huang, B., Zhu, Y., Tan, W. & Zhu, M. Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice. Cell. Mol. Immunol. 18, 749\u2013751 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"24514_CR20","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41565-020-0648-y","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang, W. et al. Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B. Nat Nanotechnol. 15, 406\u2013416 (2020).","journal-title":"Nat Nanotechnol."},{"key":"24514_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.nano.2018.11.009","volume":"16","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. Ferritin nanoparticle-based SpyTag\/SpyCatcher-enabled click vaccine for tumor immunotherapy. Nanomed. Nanotechnol. Biol. Med. 16, 69\u201378 (2019).","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"24514_CR22","doi-asserted-by":"publisher","first-page":"eabf1591","DOI":"10.1126\/sciadv.abf1591","volume":"7","author":"L He","year":"2021","unstructured":"He, L. et al. Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates. Sci. Adv. 7, eabf1591 (2021).","journal-title":"Sci. Adv."},{"key":"24514_CR23","doi-asserted-by":"publisher","first-page":"1184863","DOI":"10.3389\/fimmu.2023.1184863","volume":"14","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Self-assembled ferritin nanoparticles displaying PcrV and OprI as an adjuvant-free Pseudomonas aeruginosa vaccine. Front. Immunol. 14, 1184863 (2023).","journal-title":"Front. Immunol."},{"key":"24514_CR24","doi-asserted-by":"publisher","first-page":"7442","DOI":"10.1002\/chem.202000075","volume":"26","author":"M Liu","year":"2020","unstructured":"Liu, M., Zhu, Y., Wu, T., Cheng, J. & Liu, Y. Nanobody-ferritin conjugate for targeted photodynamic therapy. Chem. A Eur. J. 26, 7442\u20137450 (2020).","journal-title":"Chem. A Eur. J."},{"key":"24514_CR25","doi-asserted-by":"publisher","first-page":"eaay7199","DOI":"10.1126\/science.aay7199","volume":"366","author":"KO Saunders","year":"2019","unstructured":"Saunders, K. O. et al. Targeted selection of HIV-specific antibody mutations by engineering B cell maturation. Science 366, eaay7199 (2019).","journal-title":"Science"},{"key":"24514_CR26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-021-03594-0","volume":"594","author":"KO Saunders","year":"2021","unstructured":"Saunders, K. O. et al. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses. Nature 594, 553\u2013559 (2021).","journal-title":"Nature"},{"key":"24514_CR27","doi-asserted-by":"publisher","first-page":"6309","DOI":"10.1038\/s41467-022-33985-4","volume":"13","author":"D Li","year":"2022","unstructured":"Li, D. et al. Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine. Nat. Commun. 13, 6309 (2022).","journal-title":"Nat. Commun."},{"key":"24514_CR28","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1021\/acscentsci.0c00940","volume":"6","author":"MJ Lobba","year":"2020","unstructured":"Lobba, M. J. et al. Site-specific bioconjugation through enzyme-catalyzed tyrosine-cysteine bond formation. ACS Cent. Sci. 6, 1564\u20131571 (2020).","journal-title":"ACS Cent. Sci."},{"key":"24514_CR29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.bbagen.2016.10.007","volume":"1861","author":"L Calisti","year":"2017","unstructured":"Calisti, L. et al. Probing bulky ligand entry in engineered archaeal ferritins. Biochimica et Biophysica Acta. BBA Gen. Sub. 1861, 450\u2013456 (2017).","journal-title":"Biochimica et Biophysica Acta. BBA Gen. Sub."},{"key":"24514_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00402-5","volume":"5","author":"Z Liu","year":"2020","unstructured":"Liu, Z. et al. RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response. Sig. Transduct. Target Ther. 5, 1\u201310 (2020).","journal-title":"Sig. Transduct. Target Ther."},{"key":"24514_CR31","doi-asserted-by":"publisher","first-page":"101669","DOI":"10.1016\/j.isci.2020.101669","volume":"23","author":"D Wright","year":"2020","unstructured":"Wright, D. et al. Naturally acquired rift valley fever virus neutralizing antibodies predominantly target the Gn glycoprotein. iScience. 23, 101669 (2020).","journal-title":"iScience."},{"key":"24514_CR32","doi-asserted-by":"publisher","first-page":"1002430","DOI":"10.3389\/fimmu.2022.1002430","volume":"13","author":"E Takashima","year":"2022","unstructured":"Takashima, E. et al. A novel asexual blood-stage malaria vaccine candidate: PfRipr5 formulated with human-use adjuvants induces potent growth inhibitory antibodies. Front. Immunol. 13, 1002430 (2022).","journal-title":"Front. Immunol."},{"key":"24514_CR33","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1093\/nar\/gkg563","volume":"31","author":"E Gasteiger","year":"2003","unstructured":"Gasteiger, E. ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 31, 3784\u20133788 (2003).","journal-title":"Nucleic Acids Res."},{"key":"24514_CR34","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: Algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods. 14, 290\u2013296 (2017).","journal-title":"Nat. Methods."},{"key":"24514_CR35","doi-asserted-by":"publisher","first-page":"e72629","DOI":"10.7554\/eLife.72629","volume":"11","author":"ST Huber","year":"2022","unstructured":"Huber, S. T. et al. Nanofluidic chips for cryo-EM structure determination from picoliter sample volumes. Elife 11, e72629 (2022).","journal-title":"Elife"},{"key":"24514_CR36","unstructured":"Schr\u00f6dinger L, DeLano W. PyMOL [Internet]. 2020. Available from: http:\/\/www.pymol.org\/pymol"},{"key":"24514_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The protein data bank. Nucleic Acids Res. 28, 235\u2013242 (2000).","journal-title":"Nucleic Acids Res."},{"key":"24514_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12202","volume":"499","author":"M Kanekiyo","year":"2013","unstructured":"Kanekiyo, M. et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 499, 102\u2013106 (2013).","journal-title":"Nature"},{"key":"24514_CR39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12977-015-0210-4","volume":"12","author":"K Sliepen","year":"2015","unstructured":"Sliepen, K. et al. Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity. Retrovirology 12, 82 (2015).","journal-title":"Retrovirology"},{"key":"24514_CR40","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1126\/science.aat9120","volume":"363","author":"T Tokatlian","year":"2019","unstructured":"Tokatlian, T. et al. Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers. Science 363, 649\u2013654 (2019).","journal-title":"Science"},{"key":"24514_CR41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1021\/acscentsci.0c01405","volume":"7","author":"AE Powell","year":"2021","unstructured":"Powell, A. E. et al. A single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice. ACS Cent. Sci. 7, 183\u2013199 (2021).","journal-title":"ACS Cent. Sci."},{"key":"24514_CR42","doi-asserted-by":"publisher","first-page":"110143","DOI":"10.1016\/j.celrep.2021.110143","volume":"37","author":"MG Joyce","year":"2021","unstructured":"Joyce, M. G. et al. SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity. Cell Rep. 37, 110143 (2021).","journal-title":"Cell Rep."},{"key":"24514_CR43","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1006\/jmbi.1997.0970","volume":"268","author":"PD Hempstead","year":"1997","unstructured":"Hempstead, P. D. et al. Comparison of the three-dimensional structures of recombinant human H and horse L ferritins at high resolution11Edited by R Huber. J. Mol. Biol. 268, 424\u2013448 (1997).","journal-title":"J. Mol. Biol."},{"key":"24514_CR44","first-page":"265","volume":"67","author":"RG Krishna","year":"1993","unstructured":"Krishna, R. G. & Wold, F. Post-translational modification of proteins. Adv. Enzymol. Relat. Areas Mol. Biol. 67, 265\u2013298 (1993).","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"24514_CR45","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1126\/science.abb7269","volume":"368","author":"M Yuan","year":"2020","unstructured":"Yuan, M. et al. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science 368, 630\u2013633 (2020).","journal-title":"Science"},{"key":"24514_CR46","doi-asserted-by":"publisher","first-page":"E7564","DOI":"10.1073\/pnas.1705176114","volume":"114","author":"Y Wu","year":"2017","unstructured":"Wu, Y. et al. Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope. Proc. Natl. Acad. Sci. U S A 114, E7564\u2013E7573 (2017).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"24514_CR47","doi-asserted-by":"publisher","first-page":"5634","DOI":"10.1038\/s41596-021-00628-9","volume":"16","author":"Z Du","year":"2021","unstructured":"Du, Z. et al. The trRosetta server for fast and accurate protein structure prediction. Nat. Protoc. 16, 5634\u20135651 (2021).","journal-title":"Nat. Protoc."},{"key":"24514_CR48","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s43588-022-00373-3","volume":"2","author":"W Wang","year":"2022","unstructured":"Wang, W., Peng, Z. & Yang, J. Single-sequence protein structure prediction using supervised transformer protein language models. Nat. Comput. Sci. 2, 804\u2013814 (2022).","journal-title":"Nat. Comput. Sci."},{"key":"24514_CR49","doi-asserted-by":"publisher","first-page":"2102592","DOI":"10.1002\/advs.202102592","volume":"8","author":"H Su","year":"2021","unstructured":"Su, H. et al. Improved protein structure prediction using a new multi-scale network and homologous templates. Adv. Sci. 8, 2102592 (2021).","journal-title":"Adv. Sci."},{"key":"24514_CR50","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1039\/C5SC04196A","volume":"7","author":"A Leitner","year":"2016","unstructured":"Leitner, A. Cross-linking and other structural proteomics techniques: How chemistry is enabling mass spectrometry applications in structural biology. Chem. Sci. 7, 4792\u20134803 (2016).","journal-title":"Chem. Sci."},{"key":"24514_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-020-0183-8","volume":"5","author":"HD Kamp","year":"2020","unstructured":"Kamp, H. D. et al. Design of a broadly reactive Lyme disease vaccine. npj Vaccines 5, 1\u201310 (2020).","journal-title":"npj Vaccines"},{"key":"24514_CR52","doi-asserted-by":"publisher","first-page":"e01868","DOI":"10.1128\/mbio.01868-23","volume":"14","author":"D Kim","year":"2023","unstructured":"Kim, D. et al. Self-assembling Gn head ferritin nanoparticle vaccine provides full protection from lethal challenge of Dabie bandavirus in aged ferrets. MBio 14, e01868-e1923 (2023).","journal-title":"MBio"},{"key":"24514_CR53","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3390\/vaccines12050546","volume":"12","author":"ND Salinas","year":"2024","unstructured":"Salinas, N. D. et al. A self-assembling Pfs230D1-ferritin nanoparticle vaccine has potent and durable malaria transmission-reducing activity. Vaccines 12, 546 (2024).","journal-title":"Vaccines"},{"key":"24514_CR54","doi-asserted-by":"publisher","first-page":"113248","DOI":"10.1016\/j.celrep.2023.113248","volume":"42","author":"DR Martinez","year":"2023","unstructured":"Martinez, D. R. et al. Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice. Cell Rep. 42, 113248 (2023).","journal-title":"Cell Rep."},{"key":"24514_CR55","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/vaccines9030301","volume":"9","author":"PJ Wichgers Schreur","year":"2021","unstructured":"Wichgers Schreur, P. J. et al. Vaccine efficacy of self-assembled multimeric protein scaffold particles displaying the glycoprotein gn head domain of rift valley fever virus. Vaccines. 9, 301 (2021).","journal-title":"Vaccines."},{"key":"24514_CR56","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13036-025-00550-8","volume":"19","author":"MQ Rodrigues","year":"2025","unstructured":"Rodrigues, M. Q., Tambaclal, A., Kloss, B., Alves, P. M. & Rold\u00e3o, A. Baculovirus-mediated production and purification of ferritin nanoparticles for rift valley fever vaccine development. J. Biol. Eng. 19, 75 (2025).","journal-title":"J. Biol. Eng."},{"key":"24514_CR57","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","volume":"65","author":"X Chen","year":"2013","unstructured":"Chen, X., Zaro, J. & Shen, W.-C. Fusion protein linkers: Property, design and functionality. Adv. Drug Deliv. Rev. 65, 1357\u20131369 (2013).","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24514-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24514-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24514-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:02:56Z","timestamp":1763942576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24514-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24514"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24514-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors agree to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"40803"}}